Search
Seres Therapeutics Inc
MCRBAdd to Watchlist
4.830USD
+0.050+1.05%
Close 07-31 16:00（ET）Quotes delayed by 15 min
46.33MMarket Cap
LossP/E TTM
Seres Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Seres Therapeutics Inc is 8.39, ranking 102 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.06, which is -1641614.26% below the recent high of 1035.80 and -7156.74% above the recent low of -4.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.